
Professor Eric Bruckert
Disclosure details
Consulting/presentation: Amgen, Genfit, MSD, Sanofi-Regeneron, Aegerion, Ionis pharmaceuticals, Servier, Mylan, Novartis, Silence therapeutic, and AKCEA.Director of the Endocrinology-Metabolism Division and the Department of Prevention of Cardiovascular Disease at the Pitié-Salpêtrière University Hospital, Paris, France
Member of the Executive Committee of the Institute of Cardio-metabolism and Nutrition (ICAN)